EcoDrugPlus

Tubulin Beta Chain-Like

Ensembl ID : ENSDCDG00000014968
Gene Symbol: LOC114770090
2 Cross references
134 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSDCDG00000014909
Gene Symbol: LOC114770091
2 Cross references
134 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSDCDG00000026185
Gene Symbol: LOC114787936
3 Cross references
301 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSDCDG00000003710
Gene Symbol: TP53
3 Cross references
164 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSDCDG00000034444
Gene Symbol: LOC114792629
3 Cross references
145 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSDCDG00000021158
Gene Symbol: TYR
3 Cross references
203 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSDCDG00000005041
Gene Symbol: TYR
3 Cross references
197 Possible Orthologues:

Tyrosine 3-Monooxygenase

Ensembl ID : ENSDCDG00000028194
Gene Symbol: LOC114766695
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSDCDG00000019592
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSDCDG00000020825
Gene Symbol: TIE1
3 Cross references
207 Possible Orthologues:

Tyrosine-Protein Kinase Itk/tsk-Like

Ensembl ID : ENSDCDG00000029784
Gene Symbol: LOC114768032
3 Cross references
207 Possible Orthologues:

Tyrosine-Protein Kinase Itk/tsk-Like

Ensembl ID : ENSDCDG00000030104
Gene Symbol: LOC114768033
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).